Zdrowie i gospodarka · 10/09/2026

FDA Announces Fee Rate for Using Priority Review Voucher in FY 2027

The US Food and Drug Administration (FDA) has set the fee rate for using a priority review voucher for fiscal year 2027, which is based on the average cost of reviewing priority review applications versus non-priority review applications from the previous fiscal year.